Apolipoprotein C-III in patients with systemic lupus erythematosus
Abstract Background Systemic lupus erythematosus (SLE) has been associated with atherosclerotic cardiovascular disease (CV) and an altered lipid profile. High levels of apolipoprotein C-III (ApoC3) are associated with elevated triglyceride levels and an increased risk of CV. In the present study, we...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BMC
2022-05-01
|
| Rangatū: | Arthritis Research & Therapy |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1186/s13075-022-02793-y |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|